Lamotrigine versus inert placebo in the treatment of borderline personality disorder: study protocol for a randomized controlled trial and economic evaluation.

MLA

Crawford, Mike J., et al. “Lamotrigine versus Inert Placebo in the Treatment of Borderline Personality Disorder: Study Protocol for a Randomized Controlled Trial and Economic Evaluation.” Trials, vol. 16, no. 1, Jan. 2015, p. 308. EBSCOhost, https://doi.org/10.1186/s13063-015-0823-x.

APA

Crawford, M. J., Sanatinia, R., Barrett, B., Byford, S., Cunningham, G., Gakhal, K., Lawrence-Smith, G., Leeson, V., Lemonsky, F., Lykomitrou, G., Montgomery, A., Morriss, R., Paton, C., Tan, W., Tyrer, P., & Reilly, J. G. (2015). Lamotrigine versus inert placebo in the treatment of borderline personality disorder: study protocol for a randomized controlled trial and economic evaluation. Trials, 16(1), 308. https://doi.org/10.1186/s13063-015-0823-x

Chicago

Crawford, Mike J, Rahil Sanatinia, Barbara Barrett, Sarah Byford, Gillian Cunningham, Kavi Gakhal, Geof Lawrence-Smith, et al. 2015. “Lamotrigine versus Inert Placebo in the Treatment of Borderline Personality Disorder: Study Protocol for a Randomized Controlled Trial and Economic Evaluation.” Trials 16 (1): 308. doi:10.1186/s13063-015-0823-x.